News

Recommendations to streamline authorisation of new clinical trials and changes to ongoing trials to generate clinical evidence

The outcome report from the 2025 annual Multi-stakeholder platform meeting on innovation is now available.

New approach brings together clinical trial and ethics expertise to accelerate development of medicines for use ahead of or during emergencies

Following consultation with the Multi-stakeholder platform Advisory Group, new documents have been published to support sponsors in the implementation of the Clinical Trials Regulation (CTR).

The report from the annual Multi-stakeholder platform meeting in October 2024 is now available.

The ACT EU workplan for 2025-2026 outlines the initiative's areas of focus, which reflect feedback from stakeholders.

The Accelerating Clinical Trials in the EU (ACT EU) initiative has established a multi-stakeholder platform (MSP) aimed at improving the environment for clinical trials across the European Union (EU).